Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review
Open accessThe DOI matches its Crossref record; 70 of the 76 references it cites were found in a registry or an index.
Abstract
Breast cancer is affecting millions of people worldwide. If not appropriately handled, the side effects of different modalities of cancer treatment can negatively impact patients' quality of life and cause treatment interruptions. In recent years, mobile health (mHealth) interventions have shown promising opportunities to support breast cancer care. Numerous studies implemented mobile health interventions aiming to support patients with breast cancer, for example, through physical activity promotion or educational content. Nonetheless, current literature reveals that real-world evidence for the actual benefits remains unclear. In this systematic review, we focus on analyzing the methodology used in recent studies to determine the effects of mHealth applications and wearable devices on the outcome of patients with breast cancer. We followed the PRISMA guideline for the selection, analysis, and reporting of relevant studies found in the databases of Medline, Scopus, Web of Science, and Cochrane Library. A total of 276 unique records were identified, and 20 studies met the inclusion criteria. Study quality was assessed with the Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for Quantitative Studies. While many of the studies used standardized questionnaires as patient-reported outcome measures, there was minimal use of objective measurements, such as activity sensors. Adoption, drop-out rates, and usage behavior of users of the mobile health intervention were often not reported. Future work should clearly define the focus and desired outcome of mHealth interventions and select outcome measures accordingly. Greater transparency facilitates the interpretation of results and conclusions about the real-world evidence of mobile health in breast cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The findings of this review are consistent with emerging international evidence demonstrating that successful cancer care transformation increasingly relies on digital health, workforce innovation, team-based care, and community-oriented models of service delivery”
From A Scoping Review of Implemented Innovations in Cancer Care: Implications for Pan-Canadian Scaling (2026) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874 · cited 1×
“17 A review protocol was drafted for internal use, and registration was not performed.”
BackgroundThe PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2_v1 · Cited by 8,090
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment
THE WHOQOL GROUP (1998) · Psychological Medicine · doi:10.1017/s0033291798006667 · Cited by 7,933 · cited 1×
“48 To evaluate their mobile game, Kim et al 30 used the WHOQOL-BREF 49”
MethodThe Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689 · cited 5×
“(1) Export of Data (2) Gamification (3) General Education (4) Tailored Education (5) Plan or Orders (6) Reminder (7) Community Forum (9) Tracker (8) Addresses Symptoms”
BackgroundMethodInfluentialBasch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593 · cited 1×
“65,66 As the ESMO Clinical Practice Guidelines highlight, using electronic systems to collect PRO measures can be beneficial for both patients and caregivers.”
BackgroundBasch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017) · JAMA · doi:10.1001/jama.2017.7156 · Cited by 2,302 · cited 1×
“65,66 As the ESMO Clinical Practice Guidelines highlight, using electronic systems to collect PRO measures can be beneficial for both patients and caregivers.”
BackgroundThomas, B. H., Ciliska, D., Dobbins, M., & Micucci, S. (2004) · Worldviews on Evidence-Based Nursing · doi:10.1111/j.1524-475x.2004.04006.x · Cited by 2,118 · cited 1×
“20,21 Based on selection bias, study design, confounders, blinding, data collection methods, withdrawals, and dropouts, the quality is categorized as low, moderate, or strong.”
BackgroundBrady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.974 · Cited by 1,752 · cited 1×
“45 Zhu et al 41 used the FACT-B, 46 a questionnaire specifically designed for measuring the health-related QoL in patients with breast cancer.”
MethodPortenoy, R. K., Thaler, H. T., Kornblith, A. B., McCarthy Lepore, J., Friedlander-Klar, H., Kiyasu, E., Sobel, K., Coyle, N., Kemeny, N., Norton, L., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90182-1 · Cited by 1,577 · cited 1×
“In 2 of the studies, 25,34 the Memorial Symptom Assessment Scale (MSAS) 50 was used to assess comprehensive information on common cancer-related symptoms.”
MethodArmijo‐Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D., & Cummings, G. G. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01516.x · Cited by 1,539 · cited 1×
“20,21 Based on selection bias, study design, confounders, blinding, data collection methods, withdrawals, and dropouts, the quality is categorized as low, moderate, or strong.”
BackgroundUnderstanding breast cancer as a global health concern
Wilkinson, L., & Gathani, T. (2022) · The British Journal of Radiology · doi:10.1259/bjr.20211033 · Cited by 1,382 · cited 5×
“(2) A mobile application or a wearable device was used by the patients themselves as an interventional support tool.”
BackgroundMethodInfluentialSprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
Self-Esteem and Adolescent Problems: Modeling Reciprocal Effects
Rosenberg, M., Schooler, C., & Schoenbach, C. (1989) · American Sociological Review · doi:10.2307/2095720 · Cited by 843 · cited 1×
“57 Empowerment in patients with breast cancer was assessed with a Dutch version of the Cancer Empowerment Questionnaire (CEQ) in one of the studies.”
MethodSide Effects of Adjuvant Treatment of Breast Cancer
Shapiro, C. L., & Recht, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442607 · Cited by 724 · cited 1×
“7,8 In the past years, there has been increasing interest in the use of mobile health (mHealth) applications, 9-12 wearable devices, 13 and telemedicine 14 to support breast cancer management.”
BackgroundMeasurement of Adults' Sedentary Time in Population-Based Studies
Healy, G. N., Clark, B. K., Winkler, E. A. H., Gardiner, P. A., Brown, W. J., & Matthews, C. E. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.05.005 · Cited by 628 · cited 1×
“68 Furthermore, expanding the scope of objective measurements to include physiological parameters such as heart rate or blood pressure can also lead to a deeper understanding of patient health and new opportunities in tailoring therapies.”
BackgroundCleland, C. L., Hunter, R. F., Kee, F., Cupples, M. E., Sallis, J. F., & Tully, M. A. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1255 · Cited by 609 · cited 1×
“53,54 Chung et al 23 included a step counter into their application.”
BackgroundMeyerowitz-Katz, G., Ravi, S., Arnolda, L., Feng, X., Maberly, G., & Astell-Burt, T. (2020) · Journal of Medical Internet Research · doi:10.2196/20283 · Cited by 561
Chan, A. H. Y., Horne, R., Hankins, M., & Chisari, C. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14193 · Cited by 523 · cited 1×
“59 The adherence to the therapy of the participants in the study of Yu et al 40 was assessed through medical staff, usually the follow-up specialist or a nurse using predefined criteria.”
MethodDi Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.04.007 · Cited by 509 · cited 1×
“67 mHealth interventions have a great potential to streamline e856 The Oncologist , 2023, Vol. 28, No. 10 the implementation of PROs in clinical by enabling remote data collection, longitudinal monitoring, and individual feedback systems.”
BackgroundAssessment of Depression and Anxiety in Breast Cancer Patients: Prevalence and Associated Factors
(2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.6.1661 · Cited by 435 · cited 1×
“7,8 In the past years, there has been increasing interest in the use of mobile health (mHealth) applications, 9-12 wearable devices, 13 and telemedicine 14 to support breast cancer management.”
BackgroundFallowfield, L. J., Leaity, S. K., Howell, A., Benson, S., & Cella, D. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006263818115 · Cited by 354 · cited 1×
“48 To evaluate their mobile game, Kim et al 30 used the WHOQOL-BREF 49”
MethodChallenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review
Amagai, S., Pila, S., Kaat, A. J., Nowinski, C. J., & Gershon, R. C. (2022) · Journal of Medical Internet Research · doi:10.2196/35120 · Cited by 343
Late effects of breast cancer treatment and potentials for rehabilitation
Ewertz, M., & Jensen, A. B. (2011) · Acta Oncologica · doi:10.3109/0284186x.2010.533190 · Cited by 309 · cited 1×
“3,4 These therapies can lead to a range of adverse effects that can impact the quality of life (QoL) of patients, 5,6 such as nausea, fatigue, hair loss, and insomnia, among others.”
BackgroundThe Treatment of Breast Cancer
(1974) · Springer eBooks · doi:10.1007/978-94-011-7152-6 · Cited by 280
The 14-item health literacy scale for Japanese adults (HLS-14)
Suka, M., Odajima, T., Kasai, M., Igarashi, A., Ishikawa, H., Kusama, M., Nakayama, T., Sumitani, M., & Sugimori, H. (2013) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-013-0340-z · Cited by 251 · cited 1×
“60 In the work of Park et al, 35 medication self-efficacy was measured with a self-developed scale on which no details were provided.”
MethodMendiola, M. F., Kalnicki, M., & Lindenauer, S. (2015) · JMIR mHealth and uHealth · doi:10.2196/mhealth.4283 · Cited by 213 · cited 3×
“Furthermore, the main features of mobile apps and wearable devices were investigated in greater detail and categorized according to Mendiola et al 19 into the following categories: (1) export of data, (2) gamification, (3) general education, (4) tailored education, (5) plan or orders, (6) reminder, (7) community forum…”
MethodInfluentialDevelopment of the Korean Global Physical Activity Questionnaire: reliability and validity study
Lee, J., Lee, C., Min, J., Kang, D.-W., Kim, J.-Y., Yang, H. I., Park, J., Lee, M.-K., Lee, M.-Y., Park, I., et al. (2020) · Global Health Promotion · doi:10.1177/1757975919854301 · Cited by 198 · cited 1×
“53,54 Chung et al 23 included a step counter into their application.”
BackgroundNardo, P. D., Lisanti, C., Garutti, M., Buriolla, S., Alberti, M., Mazzeo, R., & Puglisi, F. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2151584 · Cited by 185 · cited 2×
“3,4 These therapies can lead to a range of adverse effects that can impact the quality of life (QoL) of patients, 5,6 such as nausea, fatigue, hair loss, and insomnia, among others.”
BackgroundAssessment of Cancer-Related Fatigue: Implications for Clinical Diagnosis and Treatment
Jean-Pierre, P., Figueroa-Moseley, C. D., Kohli, S., Fiscella, K., Palesh, O. G., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-11 · Cited by 165
Determining the scope of the review and the questions it will address
Thomas, J., Kneale, D., McKenzie, J. E., Brennan, S. E., & Bhaumik, S. (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch2 · Cited by 164
Kim, H. J., Kim, S. M., Shin, H., Jang, J.-S., Kim, Y. I., & Han, D. H. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9559 · Cited by 151 · cited 11×
“Medication adherence was measured using the Korean Version of the Medication Adherence Rating Scale (K-MARS) 58 in the study of Kim et al 30 Visser et al 38 used the 5-item Medication Adherence Report Scale (MARS-5).”
BackgroundMethodInfluentialResearch-Tested Mobile Apps for Breast Cancer Care: Systematic Review
Jongerius, C., Russo, S., Mazzocco, K., & Pravettoni, G. (2019) · JMIR mHealth and uHealth · doi:10.2196/10930 · Cited by 146 · cited 1×
“Within the systematic e848 The Oncologist , 2023, Vol. 28, No. 10 review of Jongerius et al, 10 an overview of the measured impact of mHealth applications in empirical studies from 29 studies in breast cancer care was generated.”
BackgroundZhu, J., Ebert, L., Liu, X., Wei, D., & Chan, S. W.-C. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9438 · Cited by 124 · cited 10×
“Five studies 22,25,34,36,41 used validated questionnaires to measure symptom burden.”
BackgroundMethodInfluentialFjell, M., Langius-Eklöf, A., Nilsson, M., Wengström, Y., & Sundberg, K. (2020) · The Breast · doi:10.1016/j.breast.2020.03.004 · Cited by 118 · cited 6×
“Two records 25,40 evaluated whether the app was used.”
BackgroundMethodInfluentialRosen, K. D., Paniagua, S. M., Kazanis, W., Jones, S., & Potter, J. S. (2018) · Psycho-Oncology · doi:10.1002/pon.4764 · Cited by 106 · cited 3×
“Eight of the studies 22-24, 26,28,30, 38, 41 investigated the influence of their mHealth intervention Finally, Rosen et al 37 used the Mindful Attention and Awareness Scale (MAAS) to capture the self-assessed dispositional mindfulness of participants in their study.”
BackgroundMethodGhanbari, E., Yektatalab, S., & Mehrabi, M. (2021) · JMIR mHealth and uHealth · doi:10.2196/19262 · Cited by 104
A biopsy of Breast Cancer mobile applications: state of the practice review
Giunti, G., Giunta, D. H., Guisado-Fernandez, E., Bender, J. L., & Fernandez-Luque, L. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.10.022 · Cited by 99 · cited 1×
“7,8 In the past years, there has been increasing interest in the use of mobile health (mHealth) applications, 9-12 wearable devices, 13 and telemedicine 14 to support breast cancer management.”
BackgroundHou, I.-C., Lin, H.-Y., Shen, S.-H., Chang, K.-J., Tai, H.-C., Tsai, A.-J., & Dykes, P. C. (2020) · JMIR mHealth and uHealth · doi:10.2196/17084 · Cited by 90 · cited 2×
“In 11 of the identified studies, 24,25,27,29,30,32-34, 36 , 38, 41 one of the Three of the studies 24,36,41 made use of validated questionnaires from the Facit Group.”
BackgroundMethodHershman, S. G., Bot, B. M., Shcherbina, A., Doerr, M., Moayedi, Y., Pavlovic, A., Waggott, D., Cho, M. K., Rosenberger, M. E., Haskell, W. L., et al. (2019) · Scientific Data · doi:10.1038/s41597-019-0016-7 · Cited by 75 · cited 1×
“62-64 Transparent reporting of acceptance, dropout, and engagement is essential to interpret the findings, as they may entail a bias in the final sample.”
BackgroundFoley, N. M., O'Connell, E. P., Lehane, E. A., Livingstone, V., Maher, B., Kaimkhani, S., Cil, T., Relihan, N., Bennett, M. W., Redmond, H. P., et al. (2016) · The Breast · doi:10.1016/j.breast.2016.08.012 · Cited by 68 · cited 1×
“61 Our review reveals that descriptions of features, content, and interfaces were often limited.”
BackgroundBlount, D., McDonough, D. J., & Gao, Z. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10092015 · Cited by 68 · cited 1×
“7,8 In the past years, there has been increasing interest in the use of mobile health (mHealth) applications, 9-12 wearable devices, 13 and telemedicine 14 to support breast cancer management.”
BackgroundEvidence on the Use of Mobile Apps During the Treatment of Breast Cancer: Systematic Review
Cruz, F. O. A. M., Vilela, R. A., Ferreira, E. B., Melo, N. S., & Reis, P. E. D. D. (2019) · JMIR mHealth and uHealth · doi:10.2196/13245 · Cited by 66 · cited 1×
“This corresponds to the findings of Cruz et al, 16 where the great potential is equally emphasized, but the actual benefit remains unclear.”
ResultHanda, S., Okuyama, H., Yamamoto, H., Nakamura, S., & Kato, Y. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.01.004 · Cited by 59 · cited 7×
“51 Two studies 28,30 did not use questionnaires.”
BackgroundMethodInfluentialConstrucción y validación de una escala de autoeficacia para la actividad física
Cabrera, T. F., Anzano, S. M., Sánchez, I. M. H., Méndez, S. R., & Olmo, A. F. D. (2011) · Revista Española de Salud Pública · doi:10.1590/s1135-57272011000400009 · Cited by 58 · cited 1×
“55 In the follow-up study, they focused on upper-limb functionality and body composition.”
BackgroundLozano-Lozano, M., Cantarero-Villanueva, I., Martin-Martin, L., Galiano-Castillo, N., Sanchez, M.-J., Fernández-Lao, C., Postigo-Martin, P., & Arroyo-Morales, M. (2019) · JMIR mHealth and uHealth · doi:10.2196/14136 · Cited by 53 · cited 6×
“32,33 In their earlier study, 32 accelerometer data of the smartphone, the weight, and body composition were analyzed.”
BackgroundMethodInfluentialEffect of mobile phone app-based training on the quality of life for women with breast cancer
Çınar, D., Karadakovan, A., & Erdoğan, A. P. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.101960 · Cited by 53 · cited 4×
“In 11 of the identified studies, 24,25,27,29,30,32-34, 36 , 38, 41 one of the Three of the studies 24,36,41 made use of validated questionnaires from the Facit Group.”
BackgroundMethodInfluentialLozano-Lozano, M., Martín-Martín, L., Galiano-Castillo, N., Fernández-Lao, C., Cantarero-Villanueva, I., López-Barajas, I. B., & Arroyo-Morales, M. (2020) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2019.07.007 · Cited by 50 · cited 6×
“In 5 of the studies, 22,23,31-33 physical activity and a healthy life-style were investigated.”
BackgroundMethodInfluentialGrašič Kuhar, C., Gortnar Cepeda, T., Kovač, T., Kukar, M., & Ružić Gorenjec, N. (2020) · JMIR mHealth and uHealth · doi:10.2196/17408 · Cited by 42 · cited 5×
“One of the studies 27 evaluated the self-reported number of doctor visits and hospitalizations of patients during therapy.”
BackgroundMethodInfluentialPark, H. R., Kang, H. S., Kim, S. H., & Singh-Carlson, S. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001030 · Cited by 42 · cited 3×
“60 In the work of Park et al, 35 medication self-efficacy was measured with a self-developed scale on which no details were provided.”
BackgroundMethodVisser, A., Prins, J. B., Jansen, L., Radema, S. A., Schlooz, M. S., van Dalen, T., & van Laarhoven, H. W. M. (2018) · The Breast · doi:10.1016/j.breast.2018.05.012 · Cited by 41 · cited 10×
“Visser et al 38 The Oncologist , 2023, Vol. 28, No. 10 e853 used the SCL-90, a Dutch questionnaire.”
BackgroundMethodInfluentialÖztürk, E. S., & Kutlutürkan, S. (2021) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2021.151161 · Cited by 38 · cited 5×
“In 2 of the studies, 25,34 the Memorial Symptom Assessment Scale (MSAS) 50 was used to assess comprehensive information on common cancer-related symptoms.”
BackgroundMethodInfluentialThe Treatment of Breast Cancer
Atkins, H. (1974) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577406700415 · Cited by 36
Development and Validation of Self-Efficacy Scale for Self-Management of Breast Cancer (SESSM-B)
Lee, R., Kim, S. H., Lee, K. S., & Seo, M. K. (2012) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.2012.42.3.385 · Cited by 35 · cited 1×
“56 The Stanford Inventory of Cancer Patient Adjustment (SICPA) was used in a Chinese version in one of the studies 41 to investigate the self-efficacy of participants.”
MethodChung, I. Y., Jung, M., Park, Y. R., Cho, D., Chung, H., Min, Y. H., Park, H. J., Lee, M., Lee, S. B., Chung, S., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01505 · Cited by 35 · cited 4×
“53,54 Chung et al 23 included a step counter into their application.”
BackgroundInfluentialEvaluation of a Mobile Health Intervention to Improve Wellness Outcomes for Breast Cancer Survivors
Cairo, J., Williams, L., Bray, L., Goetzke, K., & Perez, A. C. (2020) · Journal of Patient-Centered Research and Reviews · doi:10.17294/2330-0698.1733 · Cited by 35 · cited 9×
“In 5 of the studies, 22,23,31-33 physical activity and a healthy life-style were investigated.”
BackgroundMethodInfluentialYu, J., Wu, J., Huang, O., Chen, X., & Shen, K. (2021) · Journal of Medical Internet Research · doi:10.2196/27576 · Cited by 30 · cited 4×
“Within 3 studies, 36,39,40 the application’s name was not mentioned, so it remains unclear whether these applications were published.”
BackgroundMethodInfluentialSuchodolska, G., & Senkus, E. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102364 · Cited by 30 · cited 1×
“Suchodolska et al 15 analyzed the effects of chemotherapy-related symptom reporting and management through mobile applications.”
BackgroundScholz, S., & Teetz, L. (2022) · Digital Health · doi:10.1177/20552076221074127 · Cited by 27 · cited 1×
“Furthermore, the main features of mobile apps and wearable devices were investigated in greater detail and categorized according to Mendiola et al19 into the following categories: (1) export of data, (2) gamification, (3) general education, (4) tailored education, (5) plan or orders, (6) reminder, (7) community forum,…”
BackgroundA personalized, web-based breast cancer decision making application: a pre-post survey
Wyatt, K. D., Jenkins, S. M., Plevak, M. F., Pont, M. R. V., & Pruthi, S. (2019) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-019-0924-7 · Cited by 21 · cited 6×
“39 Participants rated whether they prefer to make their own decisions or more doctor-guided decisions.”
BackgroundMethodInfluentialKong, S., Lee, J. K., Kang, D., Kim, N., Shim, Y. M., Park, W., Choi, D., & Cho, J. (2021) · Cancers · doi:10.3390/cancers13112692 · Cited by 18 · cited 4×
“22 Kong et al 31 included a WAT to accompany the mobile application.”
BackgroundMethodInfluentialPark, J., Jung, Y. S., Kim, J. Y., & Bae, S. H. (2021) · Nursing Open · doi:10.1002/nop2.1113 · Cited by 18 · cited 9×
“Five studies 22,25,34,36,41 used validated questionnaires to measure symptom burden.”
BackgroundMethodInfluentialPark, G., Lee, H., & Kim, H. Y. (2019) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.2019.49.5.550 · Cited by 14 · cited 2×
“Two of the studies 39,42 used custom scales.”
MethodTokgöz, P., & Dockweiler, C. (2021) · Die Rehabilitation · doi:10.1055/a-1480-3712 · Cited by 10
Update Breast Cancer 2022 Part 2 – Advanced Stage Breast Cancer
Müller, V., Welslau, M., Lüftner, D., Schütz, F., Stickeler, E., Fasching, P. A., Janni, W., Thomssen, C., Witzel, I., Fehm, T. N., et al. (2022) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1811-6148 · Cited by 9 · cited 1×
“3,4 These therapies can lead to a range of adverse effects that can impact the quality of life (QoL) of patients, 5,6 such as nausea, fatigue, hair loss, and insomnia, among others.”
BackgroundGomm, S. I. M., Ebner, F. K., Lukac, S., El‐Taie, Z., Janni, W. J., Schmidt, U., Stoinschek, B., & Dayan, D. (2022) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1909-8736 · Cited by 4
The Reliability and Validity of the Korean Version of Medication Adherence Rating Scale
Chang, J. G., Roh, D. D., & Kim, C. (2015) · Cited by 4
Cited by
Pappot, H., Steen-Olsen, E. B., & Holländer-Mieritz, C. (2024) · Diagnostics · doi:10.3390/diagnostics14040405 · Cited by 11
Mogharab, G. M., Khajouei, R., Norouzkhani, N., Esmaeili, Z., Bagheri, F. Z., & Habibi, M. R. M. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12838-y · Cited by 8
“This systematic review on mobile health effectiveness in breast cancer care can be used to contextualize the findings related to the impact of mobile apps on patient care [30].”
Mahalingam, L., Tan, B. K., Bee, P. C., Teoh, C. H., Sellappans, R., Ng, D.-L.-C., Husin, A., Tan, S. M., & Chen, L. (2025) · Digital Health · doi:10.1177/20552076251361221 · Cited by 5
de Jesus, N. T., Lima, M. G. A., Leitão, H. A. D. S., & Dantas, D. D. S. (2025) · BioMedInformatics · doi:10.3390/biomedinformatics5040062 · Cited by 2
Contreras-Sánchez, S. E., Doubova, S. V., Álvarez, R. G., Villalobos-Valencia, R., Borunda, A. K. D., Cerrillo, J. G. N., López, A. D. H., Montiel-Jarquín, A. J., García-Galicia, A., Talamantes-Gamez, E. I., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-15724-w · Cited by 2
“…have encompassed monitoring symptoms and treatment-related adverse events, digital communication with healthcare providers, and different forms of patient support, such as tailored informational assistance, learning forums, and ask-the-expert forums to address needs of these patients [5–7].”
Metadata
- Authors
- Flaucher, M., Zakreuskaya, A., Nissen, M., Mocker, A., Fasching, P. A., Beckmann, M. W., Eskofier, B. M., & Leutheuser, H.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Flaucher, Madeleine
- ORCID
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-08-03
- Volume
- 28
- Issue
- 10
- Pages
- e847-e858
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- PMC
- PMC10546835
- OpenAlex
- W4385515516
- Cited by
- 15
- References
- 76
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 3
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Oncologist (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Bavarian State Ministry of Health and Care (PBN-MGP-2010-0004-DigiOnko)
- Federal Ministry of Health
- German Bundestag (2519DAT400)
- German Research Foundation
- Heisenberg Professorship Programme (ES 434/8-1)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- mobile health, breast cancer, wearable devices, mobile health intervention, patient-reported outcomes, physical activity promotion, cancer treatment side effects, intervention effectiveness, study quality
- MeSH terms
- Breast Neoplasms, Delivery of Health Care, Female, Humans, Quality of Life, Telemedicine, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.